Written by Lorraine Mullaney || 2nd November 2023 || News analysis |
While its neighbours Germany and the Czech Republic continue to move closer towards legalising recreational cannabis, Austria appears to be lagging behind. The governing People’s Party is firmly against the idea ...
Written by Lorraine Mullaney || 3rd October 2023 || News analysis |
As the German government pushes ahead with its work creating a new legal framework for cannabis in the country, hemp and cannabis associations are urging politicians to fine-tune the current draft of the legislation ...
Written by Lorraine Mullaney || 27th July 2023 || News analysis |
Major cannabis firms are streamlining their North American operations and reallocating resources toward markets with what they see as more long-term growth potential ...
Written by Lorraine Mullaney || 11th May 2023 || Blogs |
German recreational legalisation – despite being watered down – will still heavily impact, but not completely eliminate, the country’s medical cannabis market ...
Written by Lorraine Mullaney || 8th February 2023 || News analysis |
US cannabis firm Curaleaf has denied having any secret financial ties to the Russian billionaire Roman Abramovich, who has been sanctioned in the UK and EU since the outbreak of the war in Ukraine ...
Written by Lorraine Mullaney || 8th February 2023 || News analysis |
British CBD and hemp brand Voyager has facilitated easier access to the EU market by acquiring a CBD extraction and manufacturing facility in Poland for £1.5m (€1.69m) ...
Written by Lorraine Mullaney || 21st December 2022 || News analysis |
US cannabis firms have been striking deals to acquire new brands, diversify their offerings and boost production capacity. Recent movers include California’s High Times and Bloomios, while two Oregon firms have teamed up ...
Written by Lorraine Mullaney || 7th December 2022 || Blogs |
Cannabis-infused drinks have been the subject of industry debate and speculation as they raise many challenges – from regulatory hurdles to dosage issues and taste formulation – but is it just a case of "when", not "if"? ...
Written by Lorraine Mullaney || 6th December 2022 || News analysis |
Ontario-based cannabis firm Canopy Growth has created a US-domiciled holding company to fast-track its expansion into “the world’s fastest-growing cannabis market” ...
Written by Lorraine Mullaney || 30th November 2022 || News analysis |
US rapper, record producer and entrepreneur Sean Combs – a.k.a. Puff Daddy, P Diddy, Diddy, or Puffy – has bought cannabis businesses in three US states in a deal valued at up to $185m ...
Written by Lorraine Mullaney || 25th November 2022 || News analysis |
Tilray Brands continues to show signs of confidence in the future of cannabis-infused drinks by adding more beverage firms to its portfolio and building a distribution network ...
Written by Lorraine Mullaney || 23rd November 2022 || News analysis |
Major US alcohol distributor Southern Glazer’s Wine and Spirits is signing increasing numbers of distribution deals to add CBD products to its portfolio ...
Written by Lorraine Mullaney || 10th November 2022 || News analysis |
It’s unlikely that any applications for novel food authorisation of CBD products in the UK will be considered for authorisation before mid-2023 – and being on the list of validated applications is no guarantee ...
Written by Lorraine Mullaney || 1st November 2022 || News analysis |
Austria’s almost non-existent regime for the use of cannabinoids in medication has been described as "a Kafkaesque nightmare" with over-officious bureaucracy putting pointless hurdles in patients' way ...
Written by Lorraine Mullaney || 21st October 2022 || News analysis |
The UK is lagging behind other major markets in the world on research into the benefits of medicinal cannabis, according to a scientist specialising in the area ...
Written by Lorraine Mullaney || 20th October 2022 || News analysis |
A major new study into the impact of cannabis on the brain has attracted controversy and accusations of bias from within the industry before it even begins ...
Written by Lorraine Mullaney || 11th October 2022 || News analysis |
Canadian firms SNDL and Valens are merging in a CAD138m deal that aims to establish one of Canada’s largest adult-use cannabis manufacturers and retailers and a global leader in cannabis products ...
Written by Lorraine Mullaney || 5th October 2022 || News analysis |
A recent study has shown that CBD can reduce the psychoactive effects of THC – a discovery which could advance the clinical application of medical cannabis ...
Written by Lorraine Mullaney || 21st September 2022 || News analysis |
A French hemp trade association believes the consortium approach applied in the initial European novel food application process could again be the solution to the requests for extra data that have stalled assessments ...
Written by Lorraine Mullaney || 15th September 2022 || News analysis |
As the US midterm elections approach, questions are being raised about the actions the Biden administration has taken to meet campaign promises regarding drug reform ...
Written by Lorraine Mullaney || 14th September 2022 || News analysis |
Despite the challenges of the market, CBD firms appear to be setting their sights on the UK and have secured some major listings in mainstream supermarkets ...
Written by Lorraine Mullaney || 26th August 2022 || News analysis |
A new conceptual inhaler designed around the idea of controlled microdosing could eventually lead to a product capable of administering precise amounts of active ingredients such as CBD, nicotine or even psychedelics ...
Written by Lorraine Mullaney || 23rd August 2022 || News analysis |
US law enforcement is working alongside toxicologists and cannabis breathalyser developer Cannabix Technologies to test and compare various methods of detecting cannabis intoxication ...
Written by Lorraine Mullaney || 23rd August 2022 || News analysis |
A US federal government publication on weights and measures is to get a new section providing guidance on cannabis standards, following a vote by officials ...
Written by Lorraine Mullaney || 22nd August 2022 || News analysis |
The US Drug Enforcement Administration (DEA) has issued a pre-solicitation notice to approved medical cannabis producers, the next step in securing new suppliers of cannabis for research purposes after a monopoly was ended ...
Written by Lorraine Mullaney || 16th August 2022 || News analysis |
Members of the US House of Representatives have approved a bill to expand and streamline research into CBD and cannabis. The bill is now heading for the Senate and is expected to reach president Joe Biden’s desk ...
Written by Lorraine Mullaney || 8th August 2022 || News analysis |
The US Drug Enforcement Administration (DEA) has withdrawn its proposal to effectively ban five psychedelic compounds after receiving significant opposition from the research and advocacy community ...
Written by Lorraine Mullaney || 5th August 2022 || News analysis |
The Channel Island of Jersey is continuing to build its cannabis industry, awarding its fifth cultivation licence to a startup amid calls from officials for stricter regulation ...
Written by Lorraine Mullaney || 4th August 2022 || News analysis |
One of the first companies involved in medical cannabis is the latest bankruptcy casualty in the volatile global cannabis market – citing slower than expected sales due to more rigorous than expected regulations ...
Written by Lorraine Mullaney || 2nd August 2022 || News analysis |
Regulatory change in Canada’s provinces, and the lack of it at federal level in the US, are both encouraging innovation by providers of financial services to cannabis businesses ...
Psychedelics are having another moment in the spotlight. But is the heightened awareness just hype, or have these once-taboo substances been permanently rehabilitated? ...
Written by Lorraine Mullaney || 19th July 2022 || News analysis |
Biotechnology firm Awakn Life Sciences has secured UK government funding to accelerate the route to the UK and US markets for its proprietary ketamine-assisted therapy, which is designed to treat alcohol use disorder ...
Written by Lorraine Mullaney || 14th July 2022 || News analysis |
Quebec-based Neptune Wellness Solutions has become the latest firm to exit the Canadian cannabis market, switching focus to its consumer packaged goods business, where it sees more potential ...
Written by Lorraine Mullaney || 11th July 2022 || News analysis |
The growth potential of demand for medicinal cannabis is inspiring cross-border acquisitions of pharmaceutical brands as businesses scale up to take a bigger slice of the global market ...
Written by Lorraine Mullaney || 7th July 2022 || News analysis |
Israeli cannabis firm InterCure is collaborating with US brand Cookies to launch Europe’s first flagship Cookies store in Vienna; meanwhile, Panaxia Labs exports to Germany from Malta ...
Written by Lorraine Mullaney || 1st July 2022 || News analysis |
Utah’s Native American namesake – the Ute tribe – has launched a company to manufacture products that combine hemp-derived cannabinoids with plants they have traditionally used for medicinal purposes ...
Written by Lorraine Mullaney || 24th June 2022 || News analysis |
A bipartisan group of 23 US state attorneys general have joined calls to halt the sale of edible cannabinoid-containing products that imitate the look of well-known brands ...
Written by Lorraine Mullaney || 22nd June 2022 || News analysis |
North American cannabis firms are attempting to muscle in on the German medical cannabis scene – possibly in an attempt to establish themselves in the market before a recreational regime is established ...
Written by Lorraine Mullaney || 17th June 2022 || News analysis |
Germany should plan ahead to avoid problems which have plagued governments that have already legalised recreational cannabis on top of medical cannabis ...
Written by Lorraine Mullaney || 31st May 2022 || News analysis |
The US is in danger of being left behind the burgeoning global cannabis market because of a lack of political will to commit to any form of federal cannabis reform ...
Written by Lorraine Mullaney || 27th May 2022 || News analysis |
Strangely, Brexit and then the Covid-19 pandemic have combined to create ideal conditions for the UK to potentially become a leader in psychedelics research ...
Written by Lorraine Mullaney || 20th May 2022 || News analysis |
The need to improve sleep is one of the main reasons why US consumers buy CBD, according to CBD-Intel’s latest market research; however, a recent report from a CBD watchdog claims that 60% of the CBD products marketed...
Written by Lorraine Mullaney || 19th May 2022 || News analysis |
Canadian cannabis companies are about as well-liked as some of the country’s biggest oil refiners and transporters – a strange position for purveyors of one of the most mellow products on the market ...
Written by Lorraine Mullaney || 19th May 2022 || News analysis |
A small change in proposed legislation could make it significantly easier to prevent the sale of “lookalike” cannabis products that work off existing well-known trademarks ...